Hence, after treating the tumor cells with CD11c and anti-PD-L1 antibodies, immunofluorescence analysis can be performed by flow cytometry or laser scanning confocal microscopy to quantitatively determine the level of PD-L1 expression on CD11c+ DCs. This evidence concerns the gene ITGAX and neoplasm.